| Name | Genedrive |
|---|---|
| Epic | GDR |
| Isin | GB00B1VKB244 |
| Industry | Medical Equipment and Services |
| Latest share price | 2.10p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £11.41 | Debt ratio | n/a |
| Shares in issue | 543.14 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -98.77 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -4.7 | 52-week high / low | 1.45p / 7.80p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Genedrive |
|---|---|
| Address | 48 Grafton Street, Manchester UK, M13 9XX |
| Telephone | +44 (0)161 606 7258 |
| Website | http://www.genedrive.com |
| Director | Position |
|---|---|
| Dr Gino Miele | CEO |
| Mr Russell Shaw | CFO |
| Mr Tom Lindsay | Non-Executive Director |
| Mr Chris Henry Francis Yates | Non-Executive Director |
| Dr Ian David Gilham | Non-Executive Chairman |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 30/06/24 | 30/06/23 | 30/06/22 |
| Intangible asssets and goodwill | n/a | n/a | n/a |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 0.17 | 0.39 | 0.21 |
| Inventory / work in progress | 0.38 | 0.53 | 0.75 |
| Trade and other receivables | 0.38 | 0.16 | 0.11 |
| Cash and equivalents | 5.19 | 2.6 | 4.59 |
| Other current assets and asset held for resale | 0.68 | 0.83 | 0.97 |
| Total of all assets | 6.8 | 4.51 | 6.62 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 1.44 | 2.45 | 1.01 |
| Long term liabilities | n/a | 0.02 | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 1.44 | 2.47 | 1.01 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 5.36 | 2.04 | 5.61 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 8.15 | 1.48 | 1.39 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -57.44 | -52.22 | -47.07 |
| Share premium account | n/a | n/a | n/a |
| Total equity | 5.36 | 2.04 | 5.61 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -5.31 | -5.22 | -5.62 |
| Pre-tax profit | -7.75 | -5.98 | -5.63 |